Objectives Identify costs, outcomes and stakeholders' perspectives associated with incorporation of community pharmacy services into the Thai National Health Insurance System and their values to all stakeholders. Methods Using a combination of search terms, a comprehensive literature search was performed using the Thai Journal Citation Index Centre, Health System Research Institute database, PubMed and references from recent reviews. Identified studies were published between January 2000 and December 2014. The review included publications in English and Thai on primary research undertaken in community pharmacies associated with the National Health Insurance System. Two independent authors performed study selection, data extraction and quality assessment. Key findings The literature search yielded 251 titles, with 18 satisfying the inclusion criteria. Clinical outcomes of community pharmacy services included control and reduction in blood pressure and blood sugar, improved adherence to medications, an increase in acceptance of interventions, and an increase in healthy behaviours. Thirty-three percentage of those at risk of diabetes and hypertension achieved normal blood sugar and blood pressure levels after being followed for 2-6 months by a community pharmacist. The cost of collaborative screening by community pharmacies and primary care units was US$ 4.5. Diabetes management costs were US$ 5.1-30.7. Community pharmacists reported high satisfaction rates. Stakeholders' perspectives revealed support for the community pharmacists' roles and the inclusion of community pharmacies as partners with the National Health Insurance System. Conclusions Community pharmacy services improved outcomes for diabetic and hypertensive patients. This review supports the feasibility of incorporating community pharmacies into the Thai National Health System.
Introduction
Community pharmacy practices have been undergoing significant development and transformation worldwide. [1] [2] [3] In Thailand, community pharmacies operate within the private sector. A community pharmacy does not have to be owned by a licensed pharmacist, but the law (Drug Act of 1957) requires each pharmacy to employ a full-time licensed pharmacist. [4] Registration with the Provincial Ministry of Public Health or Ministry of Public Health in Bangkok is required prior to opening a community pharmacy. As of 2014, there were 33 241 licensed pharmacists and 15 359 community pharmacies, [4] with approximately 1000 new pharmacists being licensed each year. community pharmacist does not require a prescription. [6] Over the past few decades, community pharmacies have been evolving from primarily commercial to more patient-centred, outcomes-oriented organizations. Since 2001, there have been significant reforms made to the Thai healthcare system. In 2002, the government launched universal health coverage and established the National Health Security Office (NHSO) by the National Health Security Act. In 2003, the Pharmacy Council announced the Accreditation Standards scheme for community pharmacies, in collaboration with the Thai Food and Drug Administration (Thai FDA). As of 2016, only 1005 of 15 359 community pharmacies were accredited. [7] The five accreditation standards cover place management (specific service areas within the pharmacy are well marked), pharmacy service management (e.g. different uniforms for pharmacists and cashiers, documents for patient follow-up, continuing education), good pharmacy practice (GPP) (e.g. procurement, stock management, sale promotion, pharmacy services), adherence to regulations (e.g. licensure, patients' rights, controlled substances logs, no sale of alcohol and cigarettes) and community participation (e.g. campaign, incorporate with a community for solving community problems). In 2013, the GPP law was enacted for community pharmacies, to ensure that prescription medications and dangerous drugs would be dispensed only by a pharmacist. Since 2001, there have been a significant number of research studies published on the clinical practices delivered by community pharmacies. [8] In other countries, research has documented and evaluated the emerging roles of community pharmacies in activities such as disease management and public health. [9] [10] [11] Disease management has included depression, osteoporosis screening, palliative care, arthritis, cardiovascular disease, asthma, diabetes and hypertension. [9] The public health initiatives have focused on family planning, availability of emergency contraception, heart disease care and prevention, general education on disease prevention, routine follow-up, consultation, immunization (influenza and pneumococcal), and osteoporosis screening and counselling. Migrant and community health centres provide general health screening, education and disaster relief. [10] Similarly in Thailand, new community pharmacy services have been implemented, with results analysed and reported in two review articles. [8, 12] The first review article described the various activities delivered that were supported by the NHSO by community pharmacies. These activities included health screening, home care, promotion of the quality use of medicines, prescription refills and reviews of medication use. Cognitive services were also offered, which focused on smoking cessation and weight loss. [12] The second review article listed 62 research papers related to community pharmacy services, including published and unpublished research. The services covered were quality use of medication, lifestyle modification, health screening and referral, prescription refills, home care, treatment of common illnesses, weight control and smoking cessation. [8] Most services were piloted and evaluated over a short period of time, and submitted as research projects to their university's database. Neither review reported outcomes of the studies. [8, 12] Although community pharmacies are a private service system, in many countries they receive government support for delivering public health services. [13] [14] [15] For example, in England the community pharmacy is recognized by the Department of Health as the main contributor to primary care and public health services under the auspices of the National Health Service. These pharmacies provide such services as medication use review, supervised administration of methadone, and smoking cessation support. [14] In Australia, pharmacists are key partners in the government's National Medicines Policy; in addition, the Third Community Pharmacy Agreement funds cognitive pharmaceutical services (e.g. medication review and the provision of written drug information). [15] In Thailand, however, formal government support of community pharmacy services is still limited. [13] The idea of incorporating community pharmacy services into the National Health Insurance System has been in development since 2001. Accordingly, many pilot projects have been performed in various locations throughout Thailand for the purpose of evaluating applicable models of community pharmacy services. The opportunity for community pharmacies to be in partnership with the NHSO has been discussed for some time, such that a rudimentary plan has been created for incorporating community pharmacy services into the National Health Care System, with the support of the NHSO, Community Pharmacy Association Thailand (CPA), and the Thai FDA. However, the previous pilot studies did not investigate key consequences including outcomes, costs or stakeholders' perspectives. Therefore, the objectives of this systematic review were to evaluate the outcomes of services, the costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System, together with their values to all stakeholders (administrators, providers and patients).
Methods

Definition of community pharmacy services
Community pharmacy services in this study covered (1) pharmaceutical care (optimal use of medication by identifying, resolving and preventing drug-related problems to improve quality of life in an individual patient) [16] and (2) health promotion (enabling people to increase control over and improve their health, including lifestyle modification, health awareness and the rational use of medicines when necessary). [17] Search strategies PubMed (Medline) is an international database and one of the primary medical research databases used to identify publications for this review. The Journal of Health System Research database, organized by the Health System Research Institute (HSRI), and the Thai Journal Citation Index Centre (TCI) were also used for the initial search. A hand search was also performed in which all the references cited in previous reviews [8, 12] were screened for studies that met our inclusion criteria. A combination of search terms was used to identify papers describing studies of pharmaceutical care or public health services provided by community pharmacies in Thailand and covered by the National Health Insurance scheme (described primarily in the supplement). The searches were restricted to articles published between January 2000 and December 2014 in either the Thai or English languages. All identified titles and abstracts were independently screened and selected by two authors.
The keywords and strategies used as in Table S1 were 'drug store', 'community pharmacy', 'community pharmacy AND pharmaceutical care', 'community pharmacy AND Health insurance', 'drug store AND pharmaceutical care', 'drug store AND Health insurance', 'community pharmacy AND Thailand', 'community pharmacy AND National Health Insurance AND Thailand', 'community pharmacy AND cost AND Thailand', 'community pharmacy AND pharmaceutical care AND Thailand' and 'drug store and Health Insurance'.
Inclusion criteria
The authors included (1) research studies available in full-text format, (2) studies which related to a community pharmacy service, (3) studies which were aimed at evaluating the incorporation of community pharmacy service into the National Health System, funded by one or more of the four key stakeholders (the NHSO, the Thai Health Organization, the Thai FDA and the HSRI, (4) studies which related to referral services from a community pharmacy to a government healthcare organization, and (5) studies which explored the perspectives of stakeholders to the pilot projects or the incorporation of services within the National Health System.
Exclusion criteria
The authors excluded studies if they were not related to a pharmaceutical care activity, such as inventory management, evaluation of business growth, development of a model that was not related to patients, evaluations of an apprenticeship/clerkship and those studies that were not original research.
Data extraction
A data extraction form was developed as a modification of the form used by Zaza et al. [18] A Microsoft Excel spreadsheet was used to sort retrieved articles by publication year, author(s), title, study design, inclusion criteria checklists to determine eligibility and duplication, patients, intervention and outcomes. The sorting was performed by one of the authors. Two authors independently performed study selection. A quality assessment with a consensus process was utilized to address disagreements.
Critical appraisal of studies
A checklist for assessing methodological quality for four different study designs (quantitative, qualitative, economic and survey studies) was developed using materials from Greenhalgh, [19] the Center for Evidence-Based Management, and a critical review form from the Duke University Medical Center library. The checklist was designed to assess bias and generalizability, rationale of the research question, sample definition and selection, description of the intervention, measurement and outcomes, and performance of the analysis. A summary of the quality assessment criteria is shown in Table 1 . The quality of the evidence was assessed for each study and independently appraised by two researchers. Each criterion was assigned a value of one point and the percentage of scores achieved was calculated. A paper was to be included in the final analysis if it met at least 75% of all criteria listed under each study type.
Data analysis
A narrative synthesis of the included studies was undertaken. Outcomes were grouped into three domains: quality of services, opinion of the stakeholders and a cost analysis for reimbursement.
Results
Of the 251 titles identified, 28 articles initially met the inclusion criteria. When assessing the quality of the evidence by peer-review following the criteria in Table 1 , 18 studies were acceptable and eligible for analysis (Figure 1) . Of the 18 articles, one article provided more than one outcome; thus, the total number of papers when grouping by outcomes was 20. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] Ten studies were excluded due to a high dropout rate [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] and/or small sample size, [40, 43] as shown in Table 2 .
Most of the identified studies were performed in northeastern Thailand (10 of 18). [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] All of the studies were project-based studies that operated on an annual budget. Table 1 A checklist for assessing the quality of evidence collected using four research methods
Research methods
Quantitative study/Therapeutic study 1. Original study: a new study or extension of a previous study, which provided more information than that which was published in previous studies 2. Recruitment: detailed explanation of the recruitment method, inclusion and exclusion criteria, and consideration of the subjects' real-life circumstance 3. Study design: detailed explanation of the specific intervention, measurements, and outcomes assessed 4. Research design: to avoid systemic bias, only the randomized controlled trial (RCT) was considered 5. Statistical analysis: results which considered the size of the sample, duration of follow-up and completeness of follow-up Qualitative study 1 
Identification
Titles and abstracts identified through database searching (n = 226)
Records after duplicates removed (n = 250)
Records screened for abstracts (n = 250) Records excluded (did not meet inclusion criteria) (n = 222)
Full-text articles assessed for eligibility (n = 28)
Full-text articles, no peer review articles and quality less than 75% were excluded. and those with high total cholesterol levels (47%). Most common modifiable cardiovascular risks giving rise to those abnormalities were inadequate exercise and elevated body mass index
Repetitive study of Khumsikiew et al., [28] study without control group, high dropout rate [20] [21] [22] [23] [24] [25] 28, [30] [31] [32] two qualitative studies, [26, 33] three survey studies, [34] [35] [36] and three economic studies [27, 29, 37] that met all of the quality assessment criteria. Three studies were randomized controlled trials, [20, 24, 25] three studies were clinical trials with a control group, [21, 22, 31] and four were clinical trials without a control group. [23, 28, 30, 32] For the economic study, there was no analysis for the incremental costs and effects of each strategy. The quality assessment results are presented in Table 3 .
Outcomes of the community pharmacy services Table S2 shows six services provided by the community pharmacies in this review, including pharmaceutical care activities for hypertension, [20] fungal skin infection, [21] prescription refills [22, 31] and home medical care. [32] Screening and weight management [25] were the health promotion services for people at risk of hypertension, diabetes and obesity. The follow-up service for lifestyle modification was also classified as a health promotion. [20, 23, 24, 30] In one of the studies that evaluated pharmaceutical care activities, Sookaneknun et al. [20] showed significant reduction in blood pressure and improvement in lifestyle modification after receiving pharmaceutical care from community pharmacies as opposed to the PCUs. A pharmaceutical care plan with treatment modification was developed and accepted by doctors more than 50% of the time. Pharmaceutical care for superficial fungal skin infection was shown to be beneficial, with a cure rate of 76.7% when treatment was directed by a community pharmacy. [21] Refill prescription service for patients with diabetes and hypertension was piloted in two studies. [22, 31] Hospitals supplied the patients' medications to community pharmacies, and the patient was scheduled to see a primary care physician every 6 months. The results showed the same clinical outcomes in patients who refilled their medications at the community pharmacy and those who refilled at the PCUs/hospital. [22, 31] Patients were highly satisfied with the pharmaceutical care service. [31] Home-based medical care was performed by community pharmacists in Bangkok, which improved adherence and blood pressure control in patients with diabetes. [32] The prevalence of people with a high risk for hypertension and diabetes was 17.5% and 6.3-12.7%, respectively. [23, 24, 28, 30] In one of the studies that evaluated health promotion services, Somsaard et al. [23] evaluated the screening programme in two community pharmacies and in one local community. It showed the prevalence of new cases of chronic diseases confirmed by a doctor at a PCU to be 9% (9 of 100 people): one diabetes, four hypertension, one hypertension and diabetes, two dyslipidaemia, and one renal failure. Forty-five people who were at risk of diabetes and hypertension received counselling from pharmacists for 2-6 months, resulting in lifestyle modification in 15 people (33.3%) and facilitating a return of their blood pressure and blood glucose levels to within the normal range. Patients were highly satisfied with the pharmacy screening services. Wongpattanatanadeach et al. [24] showed significant changes in diet, alcohol consumption and exercise behaviour in pre-hypertensive individuals 2 months after receiving counselling and health education from a community pharmacist. While only slight weight reductions were observed 4 months after counselling, the knowledge of and improvement in healthy eating behaviours improved following initiation of community pharmacy services. [25] Perspectives of relevant stakeholders to Thai community pharmacy Five studies explored the perspectives of various stakeholders on the current state of health care, recommending that community pharmacists should be involved in providing disease management and health promotion, with a special emphasis on smoking cessation and control of alcohol intake (Table S2) . Arkaravichien et al. [26] used the Delphi technique to explore the opinions of 21 policymakers and academics with direct experience in the pharmacy profession. All strongly supported the role of community pharmacies in disease management and health maintenance. Thananithisak et al. [35] queried 164 participating pharmacists on their perception of tobacco control services provided by community pharmacies, following a 1-day training workshop designed to guide smoking cessation services. Subsequent to the workshop, 51% of the participating pharmacists provided tobacco control activities. Barriers to effective training of patients included a lack of demand, education materials, cessation products, knowledge and skill, follow-up visits, time, and reimbursement. Individuals who consumed alcohol requested counselling services on alcohol control from the community pharmacists. A survey [34] of 465 people who either drank, or were addicted to alcohol indicated a desire for community pharmacists to provide (1) advice about risks of alcohol drinking during pregnancy and lactation, (2) information on alcohol-drug interactions, (3) advice on how to reduce/stop alcohol consumption and (4) a need for private counselling regarding alcohol consumption. Nimpitakpong et al. [36] showed that a brief and comprehensive training programme provided community pharmacists with the education and skills needed to render necessary services. Of the pharmacists who attended the programme and returned the questionnaire, 71.1% (707/ 994) were able to provide the service. Of the 707 respondents, provision of brief advice (education on the risks associated with smoking, along with distribution of informational leaflets) was provided for 47.4% (335/707), the 4A's smoking cessation service was provided for 37.3% (264/707), and comprehensive services (the 5A's: ask, advise, assess, assist, and schedule for follow-up) were provided for 15.3% (108/707).
One potential model for community pharmacy-based healthcare services was suggested in a study conducted by four classes of stakeholders: policymakers, healthcare providers, academicians and health professionals (including physicians). The model proposed the incorporation of a Pharmacy Council-accredited community pharmacy [33] into the National Health Insurance System, as a subcontractor under the Universal Coverage Scheme. Table S2 summarizes three studies related to economic outcomes and estimates the reimbursement rate for community pharmacy in delivering pharmaceutical care activities and health promotion services. Sookaneknun et al. [29] reported the unit cost of screening in two community pharmacies to be US$ 11.2. This group also found that one of 51 patients screened (2%) was a new hypertension patient. The cost of screening in seven local communities was US$ 4.3; here they found that one out of 405 patients screened (0.3%) was a new hypertension patient. The combined model of community pharmacy with local communities cost US$ 5.1 and identified two new hypertension patients of 456 people (0.4%). Kessomboon et al. [27] determined that, depending on the activity, the cost estimation of disease management by community pharmacists was 182-1044 Baht (US$ 5.10-29.10) for a patient with diabetes and 182-1098 Baht (US$ 5.1-30.7) for a patient with hypertension. Thavorn and Chaiyakunapruk [37] estimated the cost of the structured community pharmacist-based smoking cessation programme by considering the summation of the pharmacists' training costs, the pharmacist fees and the costs of medication. The total cost of the smoking cessation programme was 6039.2 Baht (US$ 168.6), resulting in a cost savings for the health system of US$ 500 in men and US$ 614 in women. There was an increase in life expectancy of 0.2 years for both men and women.
Cost analysis for reimbursement
Discussion
This literature search yielded 251 titles, of which 18 satisfied the inclusion criteria. The services provided by Thai community pharmacies were frequently related to pharmaceutical care (e.g. advice about medicines, home medical care, and lifestyle modification) and screening for risk of chronic diseases. The quantifiable clinical outcomes of services offered by community pharmacies included improvements in blood pressure, blood sugar, medication adherence and healthy behaviours. Community pharmacists reported high customer satisfaction ratings regarding the delivery of these services. Similar agreement was found among other relevant stakeholders. The suggested reimbursement rates varied depending on the type of services offered and diseases that the services targeted.
Three databases and a hand search were used to conduct a thorough and systematic review. The review included English and Thai language articles that were available in full text, which generated findings that were of great relevance for Thailand. Instances of potential publication bias were noted. During the course of the rigorous review of articles, a number of pilot studies and unpublished studies were not incorporated. These studies focused on provision of services such as promoting correct use of medicines, voluntarily counselling, testing individuals at risk of HIV, and advice on smoking-related illnesses.
The results generated from this and previous reviews [48, 49] confirmed the benefits of community pharmacy services on a wide variety of public health issues, especially prevention of non-communicable diseases. In 2016, Sabater-Hern andez et al. [48] conducted a systematic review of 16 studies which highlighted the positive impacts of community pharmacy on cardiovascular health, evidenced by improved clinical measures (e.g. HbA1c, fasting plasma glucose, blood pressure), greater adherence to administration of medications, and enhancement of patients' knowledge. This is similar to our findings showing that broadening the services offered by community pharmacies in Thailand tends to improve those clinical parameters. Because of the high cost of HbA1c testing, it is not routinely checked; therefore, we did not include studies in our review where HbA1c levels were measured. Moreover, the results from this review did not show any difference in the quality of services offered by community pharmacies compared to that provided by hospitals. [22, 31] Two RCTs [20, 30] included in our review compared effectiveness of lifestyle modification over a 2-to 6-month period, monitoring blood pressure/ sugar and body weight, three common key outcomes used by other studies. [49] Our review included two studies [25, 28] which used a lifestyle assessment tool and the Theory of Planned Behavior questionnaire to provide weight management. Lifestyle modification in patients with chronic diseases was frequently reported as one of the community pharmacy services. [20, 24, 30] Because of the increased prevalence of diabetes and hypertension, the Ministry of Public Health has urged the healthcare sector to provide screening services for individuals 35 years of age and older. Our findings illustrate that the community pharmacist has the potential to make a significant impact on this campaign. However, as seen in a few studies, community health workers (CHWs) can also participate in the screening process, [50] teaching patients to understand the need to control their illnesses. [51] The involvement of CHWs in the delivery of health care in Thailand is unique, and thus has been acknowledged by the World Health Organization [52] as a key mechanism for promoting good health in rural areas. Nevertheless, the effectiveness of healthcare activities provided by CHWs needs to be confirmed. [50] For example, Sookaneknun et al. [29] reported a lower rate of referral of high risk hypertensive clients to hospitals by CHWs (4.7%), compared with the rate of referrals by community pharmacies (22.7%).
Most of the included studies were performed in northeastern Thailand between 2008 and 2016 under the MOU between two pharmacy schools and the Regional NHSO. These studies focused on evaluating outcomes of pharmacy-based services that included screening for diabetes, hypertension, and HIV, as well as support for smoking cessation and home-based pharmaceutical care. In 2014, this had been seen as a model for what community pharmacy professionals could deliver, which expanded to other regions with the support of the Community Pharmacy Association, Thailand (CPA) and the NHSO, Bangkok. This illustrates that professional organizations support the idea of engaging community pharmacies in the national health system.
Our review shows that stakeholders support the incorporation of Thai community pharmacies into the National Health Service. However, this collaboration has not yet been formally established. One obstacle that may prevent this collaboration from being successful is the lack of a mechanism for reimbursement to community pharmacies. Economic analyses of community pharmacy services were performed, with conclusions being that the reimbursement rate varied widely depending on the type of service offered and the nature of the disease. In addition, as mentioned by Sookaneknun et al., [29] the reimbursement process tends to be complex and time consuming, since it is regulated by the Ministry of Finance.
Presently, the best models for the incorporation of community pharmacy services into the National Health System are in Great Britain (England [14] and Scotland [53] ) and Australia. [15] The models in both of these countries are outstanding, with coordinating bodies as key partners with the government's National Medicines Policy -Pharmaceutical Services Negotiating Committee in England, Community Pharmacy Scotland in Scotland, and the Pharmacy Guild in Australia -to negotiate for the funding and reimbursement of community pharmacy services. The remuneration system helps to develop and maintain pharmacy services. [11] Community pharmacy services in Australia go beyond simply providing medicines at the counter, including such services as residential care medication reviews and home medical reviews. [11] In Great Britain, pharmacists have a role in primary care teams, and provide valuable services that have been accepted by the public, such as medication use reviews and cardiovascular screenings. [54, 55] However, limitations to the system are found in such areas as the budget squeeze, competition and supply chain pressures, consumer demands, [11, 56] inconsistency of services provided, unacceptable appointment management, insufficient follow-up advice, and time pressures when there are not enough pharmacists available to deliver services. [54, 57] Recommendations for research and policy Primary health care is an important mission for every country. Strengthening public health in the community requires public-private partnerships. Community pharmacists are widely accepted as primary care professionals who promote healthy behaviours and the proper use of medications. In recent years, a significant effort has been made to establish a government-pharmacy collaborative network in Thailand. These efforts aimed to (1) formalize a role for community pharmacists in the delivery of pharmaceutical care for diabetes into the practice guidelines established by the Diabetes Association of Thailand, [58] (2) provide health promotion services according to the Community Pharmacy Association (Thailand) [59] and GPP law launched in 2014 [60] and (3) train pharmacy preceptors to provide services recommended by the NHSO. [61] Our review underscores the numerous benefits available from community pharmacy practices and confirms the consensus among healthcare stakeholders that this incorporation is possible. In addition, the studies used herein propose a reasonable reimbursement rate, at least from the Thai perspective. In order to improve the quality of the service, well-designed research and additional studies are required. We suggest that a systematic management authority to facilitate delivery of services should be created by all parties, including policymakers, providers and service users. We also encourage support for investment in information systems to improve communication and coordination between community pharmacists and other healthcare providers. Moreover, we believe it is prudent for a professional pharmacy organization such as the Community Pharmacy Association to coordinate and oversee the subcontracting of duties and responsibilities, as well as negotiate matters of financial import on behalf of the community pharmacies. Finally, we recommend that the CUP or local health authority devise a strategy to promote service provision by community pharmacies.
Conclusions
Community pharmacy services in Thailand have continued to expand since the government implemented Universal Coverage in 2001. Healthcare stakeholders acknowledge a role for community pharmacists in providing pharmaceutical care and health promotion activities, as benefits have been clearly demonstrated for patients with diabetes and hypertension. Clinical outcomes for patients receiving community pharmacy services were not markedly different from the outcomes of patients receiving treatment from PCUs or hospitals. The reimbursement rates for these services were analysed for screening, prescription refills and smoking cessation. This review clearly demonstrates that incorporating community pharmacies into Thai National Health Insurance System is feasible, but studies examining long-term outcomes are necessary to confirm the value of such services.
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